These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase]. Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221 [TBL] [Abstract][Full Text] [Related]
9. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [TBL] [Abstract][Full Text] [Related]
10. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
11. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568 [TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196 [TBL] [Abstract][Full Text] [Related]
14. Immune-mediated necrotizing myopathy due to statins exposure. Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904 [TBL] [Abstract][Full Text] [Related]
15. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706 [No Abstract] [Full Text] [Related]
16. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019 [TBL] [Abstract][Full Text] [Related]
18. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203 [TBL] [Abstract][Full Text] [Related]